Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4M Buy
41,947
+23,717
+130% +$2.28M 0.32% 57
2026
Q1
$1.89M Buy
18,230
+5,515
+43% +$625K 0.16% 83
2025
Q4
$1.28M Sell
12,715
-420
-3% -$45.6K 0.11% 101
2025
Q3
$1.62M Buy
+13,135
New +$1.63M 0.16% 70

Other funds holding CLX

KLCM Advisors's CLX Position: Q2 2026 in Review

KLCM Advisors increased its Clorox (CLX) stake by 130% in Q2 2026, buying an estimated $2.28M and bringing the position to 41,947 shares worth $4M. The position accounts for 0.32% of the portfolio, ranked #57.

KLCM Advisors first reported a position in CLX in Q3 2025 and has held it in 4 quarters since. 1,051 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • KLCM Advisors held 41,947 shares of Clorox worth $4M as of Q2 2026.
  • KLCM Advisors bought 23,717 Clorox shares in Q2 2026, an estimated $2.28M.
  • Clorox made up 0.32% of KLCM Advisors's portfolio in Q2 2026, its #57 holding.
  • KLCM Advisors first reported a position in Clorox in Q3 2025 and has held it in 4 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on KLCM Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.